Xing, Bin <br/><br/>
Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt.  [electronic resource] 

 -  Journal of neuroinflammation  Jan 2008 
 - 4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1742-2094 
<br/><br/><label>Standard No.: </label>10.1186/1742-2094-5-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Anti-Inflammatory Agents--pharmacology<br/>Brain--drug effects<br/>Cells, Cultured<br/>Coculture Techniques<br/>Dopamine--metabolism<br/>Encephalitis--drug therapy<br/>Enzyme Activation--drug effects<br/>Hypoglycemic Agents--pharmacology<br/>Inflammation Mediators<br/>JNK Mitogen-Activated Protein Kinases--drug effects<br/>Lipopolysaccharides<br/>Microglia--drug effects<br/>Neurons--drug effects<br/>Nitric Oxide--biosynthesis<br/>Nitric Oxide Synthase Type II--drug effects<br/>PPAR gamma--antagonists & inhibitors<br/>Phosphatidylinositol 3-Kinases--drug effects<br/>Pioglitazone<br/>Rats<br/>Rats, Sprague-Dawley<br/>Thiazolidinediones--pharmacology<br/>p38 Mitogen-Activated Protein Kinases--drug effects